K. Coleman

1.1k total citations · 1 hit paper
8 papers, 839 citations indexed

About

K. Coleman is a scholar working on Pollution, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, K. Coleman has authored 8 papers receiving a total of 839 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pollution, 3 papers in Molecular Medicine and 2 papers in Infectious Diseases. Recurrent topics in K. Coleman's work include Antibiotic Resistance in Bacteria (3 papers), Animal Nutrition and Physiology (2 papers) and Pharmaceutical and Antibiotic Environmental Impacts (2 papers). K. Coleman is often cited by papers focused on Antibiotic Resistance in Bacteria (3 papers), Animal Nutrition and Physiology (2 papers) and Pharmaceutical and Antibiotic Environmental Impacts (2 papers). K. Coleman collaborates with scholars based in United States, United Kingdom and Austria. K. Coleman's co-authors include Brian P. Conlon, Vincent M. Isabella, Steve N. Leonard, Joshua Adkins, Kim Lewis, Ernesto Nakayasu, Richard Smith, L Fleck, Michael D. LaFleur and Pamela Hunter and has published in prestigious journals such as Nature, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

K. Coleman

8 papers receiving 761 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activated ClpP kills persisters and eradicates a chronic biofilm infection

2013 520 citations Brian P. Conlon, Ernesto Nakayasu et al. Nature profile →

Peers

K. Coleman

MB

MM

ID

PHARM

GENET

B Oliva Italy

W. TOSCH Switzerland

Nigel A. C. Curtis United Kingdom

H. M. Van Den Elzen Canada

Julieanne M. Bostock United Kingdom

Steve N. Leonard United States

Nuno T. Antunes United States

B Slocombe United Kingdom

Margareta Tuckman United States

Z Markiewicz Poland

B Oliva Italy

K. Coleman

379 ×0.9

MB

203 ×0.7

MM

207 ×1.1

ID

156 ×1.1

PHARM

113 ×0.8

GENET

Citations per year, relative to K. Coleman K. Coleman (= 1×) peers B Oliva

Countries citing papers authored by K. Coleman

Since Specialization

Citations

This map shows the geographic impact of K. Coleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Coleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Coleman more than expected).

Fields of papers citing papers by K. Coleman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Coleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Coleman. The network helps show where K. Coleman may publish in the future.

Co-authorship network of co-authors of K. Coleman

This figure shows the co-authorship network connecting the top 25 collaborators of K. Coleman. A scholar is included among the top collaborators of K. Coleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Coleman. K. Coleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Conlon, Brian P., Ernesto Nakayasu, L Fleck, et al.. (2013). Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature. 503(7476). 365–370. 520 indexed citations breakdown →

2.

Coleman, K., et al.. (1995). Rapid detection of antimicrobial activity using flow cytometry. Cytometry. 21(4). 374–377. 23 indexed citations

3.

BROOM, N. J. P., Gordon Bruton, Brian Clarke, et al.. (1991). 6-(Substituted methylene)penems, potent broad spectrum inhibitors of bacterial .BETA.-lactamase. III. Structure-activity relationships of the 5-membered heterocyclic derivatives.. The Journal of Antibiotics. 44(3). 331–337. 37 indexed citations

4.

Coleman, K., et al.. (1991). Pharmacokinetic studies and renal dehydropeptidase stability of the new beta-lactamase inhibitor BRL 42715 in animals. Antimicrobial Agents and Chemotherapy. 35(9). 1748–1752. 11 indexed citations

5.

Coleman, K., et al.. (1989). In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor. Antimicrobial Agents and Chemotherapy. 33(9). 1580–1587. 77 indexed citations

6.

Hunter, Pamela, et al.. (1980). In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillin. Journal of Antimicrobial Chemotherapy. 6(4). 455–470. 121 indexed citations

7.

Bunyan, J., et al.. (1977). Antimicrobial substances and chick growth promotion: The growth‐promoting activities of antimicrobial substances, including fifty‐two used either in therapy or as dietary additives. British Poultry Science. 18(3). 283–294. 33 indexed citations

8.

Coleman, K., et al.. (1977). Antimicrobial substances and chick growth promotion: Comparative studies on selected compoundsin vitroandin vivo. British Poultry Science. 18(3). 295–308. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact